Use of Cognitive Testing, Questionnaires and Plasma Biomarkers to Quantify Cognitive Impairment in an Aging Pet Dog Population

Manuscript Number: 

21-5562R2

Author(s): 
Beth Case, Gilad Fefer, Margaret E. Gruen, Michael Khan, Freya M. Mowat, David M. Murdoch, Natasha J. Olby, Wojciech K. Panek, Matthew Singer, Hans Westermeyer

Disclosures

Beth Case

  • Nothing to Disclose

Gilad Fefer

  • Nothing to Disclose

Margaret E. Gruen

  • Consulting Fees:
    I have consulted for Elanco, Zoetis, Boehringer-Ingelheim, and Assisi Animal Health.
    Lecture Fees:
    I have received speaker fees from Zoetis, Boehringer-Ingelheim, and Assisi Animal Health.
    Grants
    • Agency: 
      Boehringer-Ingelheim
      Dates: 
      6/3/2021-6/2/2022

Michael Khan

  • Nothing to Disclose

Freya M. Mowat

  • Nothing to Disclose

David M. Murdoch

  • Nothing to Disclose

Natasha J. Olby

  • Nothing to Disclose

Wojciech K. Panek

  • Nothing to Disclose

Matthew Singer

  • Nothing to Disclose

Hans Westermeyer

  • Nothing to Disclose